The effects of polydextrose and xylitol on microbial community and activity in a 4-stage colon simulator.
Level 5 - mechanism / opinion, no new human data
In vitro bench study using a multi-stage colon simulator model.
PubMed 17995737 · doi:10.1111/j.1750-3841.2007.00350.x
What was done
Researchers evaluated the metabolic effects of 2% polydextrose and 2% xylitol compared to a carbohydrate-free control using a 4-stage semicontinuous, anaerobic colon simulator mimicking the human proximal-to-distal large intestine. The system was inoculated with fecal samples from different human donors, fed synthetic small-intestinal medium, and analyzed after 48 hours of simulation for fermentation kinetics, short-chain fatty acids (SCFAs), branched-chain fatty acids (BCFAs), and biogenic amines.
What was found
The abstract reports directional shifts without reporting numerical values, effect sizes, or exact p-values. Polydextrose showed sustained degradation throughout the 4-stage colon model, whereas xylitol degraded more rapidly. Fermentation of both compounds significantly increased SCFA production (polydextrose particularly acetate and propionate; xylitol particularly butyrate) and significantly decreased BCFA levels relative to control. Biogenic amine concentrations remained mostly unchanged.
Why it matters
The study shows distinct in vitro fermentation kinetics and metabolite production profiles for polydextrose and xylitol in a simulated large intestine environment.
Limits
This is an in vitro bench model that lacks in vivo host factors, including mucosal absorption, gut motility, and host immune interactions. The abstract does not disclose the sample size (number of fecal donors) and omits all quantitative measurements, variance, and baseline donor characteristics.
Cited by
- supports Xylitol is fermented in the digestive tract to form butyrate, a protective short-chain fatty acid.